Guidelines for the diagnosis and treatment of alcoholic liver disease

Journal of Digestive Diseases

Volumn 9, Issue 2, 2008, Pages 113-116

  Zeng, Min De ^a   Li, You Ming ^b   Chen, Cheng Wei ^c   Lu, Lun Gen ^a   Fan, Jian Gao ^d   Wang, Bing Yuan ^e   Mao, Yi Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Hospital No 85   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; ANTIFIBROTIC AGENT; APOLIPOPROTEIN A1; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CHOLESTEROL; COLLAGEN TYPE 3; COLLAGEN TYPE 4; FERRITIN; FOLIC ACID; GAMMA GLUTAMYLTRANSFERASE; GLUCOCORTICOID; GLYCYRRHIZIC ACID; HYALURONIC ACID; INSULIN; LAMININ; METADOXINE; PHOSPHATIDYLCHOLINE; PROTHROMBIN; SILYMARIN; VITAMIN B GROUP; VITAMIN K GROUP;

ABDOMINAL PAIN; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ANAMNESIS; ANOREXIA; ARTICLE; CHINESE MEDICINE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ECHOGRAPHY; EVIDENCE BASED MEDICINE; FATIGUE; HISTOPATHOLOGY; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MENTAL DISEASE; NEUROLOGIC DISEASE; NUTRITIONAL SUPPORT; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; SYMPTOM; TREATMENT OUTCOME; WEIGHT REDUCTION;

CHINA; HUMANS; LIVER DISEASES, ALCOHOLIC;

EID: 42449136194     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2008.00332.x     Document Type: Article

References (15)

1. Lok AS, McMahon BJ; Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: Update of recommendations. Hepatology 2004; 39: 857-61.
2. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of alcoholic liver disease. Zhonghua Ganzangbing Zazhi 2003; 11: 72.
3. Sanyal AJ American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
4. Graif M, Yanuka M, Baraz M et al. Quantitative estimation of attenuation in ultrasound video images: Correlation with histology in diffuse liver disease. Invest Radiol 2000; 35: 319-24.
5. Ataseven H, Yildrim MH, Yalniz M et al. Correlation between computerized tomographic findings and histopathologic grade/stage in non-alcoholic steatohepatitis. J Hepatol 2003; 38 (Suppl. 2): A4177.
6. Farrell GC, George J, Hall P, de la M, McCullough, AJ. eds. Fatty Liver Disease: NASH and Related Disorders. Oxford: Blackwell, 2005.
7. McCullough AJ, O'Connor JF. Alcoholic liver disease: Proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2022-36.
8. Stickel F, Hoehn B, Schuppan D et al. Review article: Nutritional therapy in alcoholic liver disease. Aliment Pharmacol Ther 2003; 18: 357-73.
9. Mathurin P, Mendenhall CL, Carithers RL Jr. et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): Individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002; 36: 480-7.
10. Imperiale TF, O'Connor JB, McCullough AJ. Corticosteroids are effective in patients with severe alcoholic hepatitis. Am J Gastroenterol 1999; 94: 3066-8.
11. Shpilenya LS, Muzychenko AP, Gasbarrini G et al. Metadoxine in acute alcohol intoxication: A double-blind, randomized, placebo-controlled study. Alcohol Clin Exp Res 2002; 26: 340-6.
12. Medina J, Moreno-Otero R. Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 2005; 65: 2445-61.
13. Hu GP, Liu K, Zhao LS. Polyunsaturated phosphatidylcholine (Essentiale) for alcoholic/fatty liver: A systematic review. Ganzang 2005; 10: 5-7.
14. Lieber CS, Leo MA, Cao Q et al. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol 2003; 37: 336-9.
15. Murray KF, Carithers RL Jr, AASLD. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005; 41: 1407-32.